Hypertriglyceridemia: management of atherogenic dyslipidemia.

Thomas Bersot, Steven Haffner, William S. Harris, Kenneth A. Kellick, Charlene M. Morris

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Elevated triglycerides are now considered an independent risk factor for coronary heart disease and continue to be a major risk for acute pancreatitis, especially when levels exceed 1000 mg/dL (SOR: B). Elevated triglycerides are a component of atherogenic dyslipidemia and often signal the presence of other conditions (eg, metabolic syndrome, type 2 diabetes mellitus) associated with an increased cardiovascular risk (SOR: A). When evaluating a patient with elevated triglycerides, it is important to be cognizant of all atherogenic lipoproteins to more accurately determine the risk of coronary heart disease (SOR: C). Patients with hypertriglyceridemia should first achieve their low-density lipoprotein cholesterol goal, followed by their non-high-density lipoprotein cholesterol goal (SOR: C). Fibrates, niacin, and omega-3 acid ethyl esters are highly effective at reducing triglycerides, while statins are considered moderately efficacious (SOR: A).

Original languageEnglish (US)
Pages (from-to)S1-8
JournalThe Journal of family practice
Issue number7
StatePublished - Jul 2006
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Hypertriglyceridemia: management of atherogenic dyslipidemia.'. Together they form a unique fingerprint.

Cite this